The partnership unites OmniAb's transgenic antibody discovery solutions with Veraxa's ADC linker technology and conjugation expertise to propel next-generation therapeutic discovery. Veraxa will ...

The different elements of an ADC, including the antibody, the cytotoxin, and the linker can greatly affect partitioning of the ADC and the cytotoxin into the different tissues, and the incorporation ...

It is the second ADC licensed by Ipsen ... intelligence-powered screening platform, and the ADC also features an “innovative, stable, and cleavable linker coupled to a potent topoisomerase ...

That hyphen stands for the chemical linker that ties an ADC’s tumor-targeting antibody to its cytotoxic drug. While linkers may seem like little more than chemical tethers, ADC makers are ...

Araris claims its peptide linker technology overcomes limitations in current ADC technologies such as heterogeneity, aggregation in blood, and high costs. Araris CEO Dr Dragan Grabulovski told Pha ...

Ipsen is back with its second antibody-drug conjugate (ADC) deal of the year ... The candidate in question, dubbed FS001, uses a cleavable linker coupled to a potent topoisomerase I (Topo1 ...

In 2018, Han cofounded ProfoundBio. The lawsuit claims Han was aware Gavrilyuk’s work at AbbVie “involved precisely the type of ADC linkers” ProfoundBio needed. According to the lawsuit ...

The collaboration brings together OmniAb’s suite of transgenic antibody discovery solutions with Veraxa’s proprietary antibody drug conjugate (ADC) linker technology and conjugation expertise to ...

Data supporting the rationale for Baylink's innovative ADC linker technology enabling delivery of degraders, dual payload antibody drug conjugates, and high drug to antibody ratio chemotherapy ...

Through membership of JLABS, OS Therapies aims to further develop and enter the clinic with its tunable Antibody Drug Conjugate (ADC) linker-based platform that relies on pH sensitive linkers ...

The therapy also had the highest therapeutic index among Claudin18.2-based ADC competitors, he said. Suwon, South Korea-based Abtis’ assets are developed with its linker platform called Abclick.